Product Browser

Last updated: 2017/11/19

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

KLK1 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00003816-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-KLK1 full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 28.93
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-KLK1 antibody (H00003816-B01) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00003816-T01
    KLK1 transfected lysate.
    Western Blot
    QC Testing of H00003816-T01
    Lane 1: KLK1 transfected lysate ( 28.93 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Entrez GeneID:
  • 3816
  • Protein Accession#:
  • -
  • Gene Name:
  • KLK1
  • Gene Alias:
  • KLKR,Klk6,hK1
  • Gene Description:
  • kallikrein 1
  • Gene Summary:
  • Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. This protein is functionally conserved in its capacity to release the vasoactive peptide, Lys-bradykinin, from low molecular weight kininogen. [provided by RefSeq
  • Other Designations:
  • glandular kallikrein 1,kallikrein 1, renal/pancreas/salivary,kallikrein serine protease 1,tissue kallikrein
  • RSS
  • YouTube
  • Linkedin
  • Facebook